- Home
- OPK vs BZH Comparison
OPK vs BZH Comparison
Compare OPK & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | BZH |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.3M | 672.0M |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | OPK | BZH |
|---|---|---|
| Price | $1.24 | $27.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $2.28 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 3.3M | 615.9K |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | $642,067,000.00 | ★ $2,266,093,000.00 |
| Revenue This Year | N/A | $8.45 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | ★ N/A | $79.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.11 | $17.37 |
| 52 Week High | $2.04 | $27.69 |
Technical Indicators
Market Signals| Indicator | OPK | BZH |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 70.12 |
| Support Level | $1.20 | $20.31 |
| Resistance Level | $1.31 | $24.28 |
| Average True Range (ATR) | 0.04 | 1.15 |
| MACD | -0.00 | 0.31 |
| Stochastic Oscillator | 37.50 | 89.77 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.